525 related articles for article (PubMed ID: 26740106)
1. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells.
Younis RH; Han KL; Webb TJ
J Immunol; 2016 Feb; 196(3):1419-29. PubMed ID: 26740106
[TBL] [Abstract][Full Text] [Related]
2. Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma.
Bergmann C; Strauss L; Zeidler R; Lang S; Whiteside TL
Cancer Res; 2007 Sep; 67(18):8865-73. PubMed ID: 17875728
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines.
Lechner MG; Megiel C; Russell SM; Bingham B; Arger N; Woo T; Epstein AL
J Transl Med; 2011 Jun; 9():90. PubMed ID: 21658270
[TBL] [Abstract][Full Text] [Related]
4. γ-Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma.
Mao L; Zhao ZL; Yu GT; Wu L; Deng WW; Li YC; Liu JF; Bu LL; Liu B; Kulkarni AB; Zhang WF; Zhang L; Sun ZJ
Int J Cancer; 2018 Mar; 142(5):999-1009. PubMed ID: 29047105
[TBL] [Abstract][Full Text] [Related]
5. Soluble Sema4D in Plasma of Head and Neck Squamous Cell Carcinoma Patients Is Associated With Underlying Non-Inflamed Tumor Profile.
Younis RH; Ghita I; Elnaggar M; Chaisuparat R; Theofilou VI; Dyalram D; Ord RA; Davila E; Tallon LJ; Papadimitriou JC; Webb TJ; Bentzen SM; Lubek JE
Front Immunol; 2021; 12():596646. PubMed ID: 33776991
[TBL] [Abstract][Full Text] [Related]
6. Prostaglanin-E2 Potentiates the Suppressive Functions of Human Mononuclear Myeloid-Derived Suppressor Cells and Increases Their Capacity to Expand IL-10-Producing Regulatory T Cell Subsets.
Tomić S; Joksimović B; Bekić M; Vasiljević M; Milanović M; Čolić M; Vučević D
Front Immunol; 2019; 10():475. PubMed ID: 30936876
[TBL] [Abstract][Full Text] [Related]
7. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive activity of CD14+ HLA-DR- cells in squamous cell carcinoma of the head and neck.
Chikamatsu K; Sakakura K; Toyoda M; Takahashi K; Yamamoto T; Masuyama K
Cancer Sci; 2012 Jun; 103(6):976-83. PubMed ID: 22360618
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive effects of soluble factors secreted by head and neck squamous cell carcinoma on dendritic cells and T lymphocytes.
Kacani L; Wurm M; Schennach H; Braun I; Andrle J; Sprinzl GM
Oral Oncol; 2003 Oct; 39(7):672-9. PubMed ID: 12907206
[TBL] [Abstract][Full Text] [Related]
10. Semaphorin 4D promotes bone invasion in head and neck squamous cell carcinoma.
Takada H; Ibaragi S; Eguchi T; Okui T; Obata K; Masui M; Morisawa A; Takabatake K; Kawai H; Yoshioka N; Hassan NMM; Shimo T; Hu GF; Nagatsuka H; Sasaki A
Int J Oncol; 2017 Aug; 51(2):625-632. PubMed ID: 28656278
[TBL] [Abstract][Full Text] [Related]
11. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.
Hoechst B; Ormandy LA; Ballmaier M; Lehner F; Krüger C; Manns MP; Greten TF; Korangy F
Gastroenterology; 2008 Jul; 135(1):234-43. PubMed ID: 18485901
[TBL] [Abstract][Full Text] [Related]
12. T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease.
Bergmann C; Strauss L; Wang Y; Szczepanski MJ; Lang S; Johnson JT; Whiteside TL
Clin Cancer Res; 2008 Jun; 14(12):3706-15. PubMed ID: 18559587
[TBL] [Abstract][Full Text] [Related]
13. Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25-FoxP3- T cells.
Centuori SM; Trad M; LaCasse CJ; Alizadeh D; Larmonier CB; Hanke NT; Kartchner J; Janikashvili N; Bonnotte B; Larmonier N; Katsanis E
J Leukoc Biol; 2012 Nov; 92(5):987-97. PubMed ID: 22891289
[TBL] [Abstract][Full Text] [Related]
14. Semaphorin 4D in human head and neck cancer tissue and peripheral blood: A dense fibrotic peri-tumoral stromal phenotype.
Derakhshandeh R; Sanadhya S; Lee Han K; Chen H; Goloubeva O; Webb TJ; Younis RH
Oncotarget; 2018 Feb; 9(13):11126-11144. PubMed ID: 29541402
[TBL] [Abstract][Full Text] [Related]
15. Blockade of adenosine A2A receptor enhances CD8
Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
[TBL] [Abstract][Full Text] [Related]
16. Invariant NKT cells are resistant to circulating CD15+ myeloid-derived suppressor cells in patients with head and neck cancer.
Horinaka A; Sakurai D; Ihara F; Makita Y; Kunii N; Motohashi S; Nakayama T; Okamoto Y
Cancer Sci; 2016 Mar; 107(3):207-16. PubMed ID: 26679292
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer.
Dufait I; Schwarze JK; Liechtenstein T; Leonard W; Jiang H; Escors D; De Ridder M; Breckpot K
Oncotarget; 2015 May; 6(14):12369-82. PubMed ID: 25869209
[TBL] [Abstract][Full Text] [Related]
18. Dynamic changes in immune cell profile in head and neck squamous cell carcinoma: Immunomodulatory effects of chemotherapy.
Takahashi H; Sakakura K; Mito I; Ida S; Chikamatsu K
Cancer Sci; 2016 Aug; 107(8):1065-71. PubMed ID: 27228557
[TBL] [Abstract][Full Text] [Related]
19. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells.
Lechner MG; Liebertz DJ; Epstein AL
J Immunol; 2010 Aug; 185(4):2273-84. PubMed ID: 20644162
[TBL] [Abstract][Full Text] [Related]
20. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
